Oslo, Norway, 16 August 2024
Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23 rd of August 2024. Vistin Pharma will host a conference call for all shareholders and interested parties at the same day; Friday 23 rd of August at 08:30 CET. There will be a Q&A session following the management discussion.
The conference call will be held in English.
The second quarter conference call will be available via web and audio through the following access points:
Webcast: https://edge.media-server.com/mmc/p/v93s3oau
Telephone conference (online registration): https://register.vevent.com/register/BIe6d254...e4d04d1d9a
*****
For further information, please contact:
Alexander Karlsen CFO +47 97053621 alexander.karlsen@vistin.com
About Vistin Pharma | www.vistin.com
Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.
